Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related protein.
Saijoh S, Nakamura-Shima M, Shibuya-Takahashi R, Ito R, Sugawara A, Yamazaki T, Imai T, Asada Y, Matsuura K, Iwai W, Wakui Y, Abue M, Kawamura S, Katayose Y, Fujimori H, Mochizuki M, Yasuda J, Yamaguchi K, Sugamura K, Satoh K, Katori Y, Tamai K. Saijoh S, et al. Among authors: sugamura k. Biochem Biophys Res Commun. 2021 Jan 22;537:132-139. doi: 10.1016/j.bbrc.2020.11.022. Epub 2021 Jan 4. Biochem Biophys Res Commun. 2021. PMID: 33412384
BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma.
Tamai K, Nakamura-Shima M, Shibuya-Takahashi R, Kanno SI, Yasui A, Mochizuki M, Iwai W, Wakui Y, Abue M, Yamamoto K, Miura K, Mizuma M, Unno M, Kawamura S, Sato I, Yasuda J, Yamaguchi K, Sugamura K, Satoh K. Tamai K, et al. Among authors: sugamura k. Sci Rep. 2020 Dec 9;10(1):21592. doi: 10.1038/s41598-020-78539-0. Sci Rep. 2020. PMID: 33299012 Free PMC article.
BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Fukushi D, Shibuya-Takahashi R, Mochizuki M, Fujimori H, Kogure T, Sugai T, Iwai W, Wakui Y, Abue M, Murakami K, Nakamura Y, Yasuda J, Yamaguchi K, Sugamura K, Shibata C, Katayose Y, Satoh K, Tamai K. Fukushi D, et al. Among authors: sugamura k. Cancer Sci. 2021 Nov;112(11):4580-4592. doi: 10.1111/cas.15115. Epub 2021 Sep 4. Cancer Sci. 2021. PMID: 34424582 Free PMC article.
CD271 defines a stem cell-like population in hypopharyngeal cancer.
Imai T, Tamai K, Oizumi S, Oyama K, Yamaguchi K, Sato I, Satoh K, Matsuura K, Saijo S, Sugamura K, Tanaka N. Imai T, et al. Among authors: sugamura k. PLoS One. 2013 Apr 23;8(4):e62002. doi: 10.1371/journal.pone.0062002. Print 2013. PLoS One. 2013. PMID: 23626764 Free PMC article.
CD271 regulates the proliferation and motility of hypopharyngeal cancer cells.
Mochizuki M, Tamai K, Imai T, Sugawara S, Ogama N, Nakamura M, Matsuura K, Yamaguchi K, Satoh K, Sato I, Motohashi H, Sugamura K, Tanaka N. Mochizuki M, et al. Among authors: sugamura k. Sci Rep. 2016 Jul 29;6:30707. doi: 10.1038/srep30707. Sci Rep. 2016. PMID: 27469492 Free PMC article.
CD271 is a negative prognostic factor and essential for cell proliferation in lung squamous cell carcinoma.
Mochizuki M, Nakamura M, Sibuya R, Okazaki T, Abe J, Nakagawa T, Takahashi S, Yamazaki T, Imai T, Takano A, Ito H, Yokose T, Miyagi Y, Daigo Y, Sato I, Satoh K, Sugamura K, Yamaguchi K, Tamai K. Mochizuki M, et al. Among authors: sugamura k. Lab Invest. 2019 Sep;99(9):1349-1362. doi: 10.1038/s41374-019-0246-5. Epub 2019 Apr 24. Lab Invest. 2019. PMID: 31019292 Free article.
Establishment of a Monoclonal Antibody That Recognizes Cysteine-Rich Domain 1 of Human CD271.
Morita S, Mochizuki M, Shibuya-Takahashi R, Nakamura-Shima M, Yamazaki T, Imai T, Asada Y, Matsuura K, Kawamura S, Yamaguchi K, Yasuda J, Sugamura K, Katori Y, Satoh K, Tamai K. Morita S, et al. Among authors: sugamura k. Monoclon Antib Immunodiagn Immunother. 2020 Feb;39(1):6-11. doi: 10.1089/mab.2019.0040. Monoclon Antib Immunodiagn Immunother. 2020. PMID: 32069133
394 results